Skip to content

Clinical trials

Diabetic Retinopathy trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetic Retinopathy Country / region: Canada Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20041
20071
20101
20122
20162
20185
20191
20223
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Unknown status6
Terminated4
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of British Columbia3
Jaeb Center for Health Research2
Uptown Eye Specialists2
Bausch & Lomb Incorporated1
Centre hospitalier de l'Université de Montréal (CHUM)1
Chromaderm, Inc.1
Group Health Centre1
National Heart, Lung, and Blood Institute (NHLBI)1
Novartis Pharmaceuticals1
PulseMedica1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetic Retinopathy20
Diabetes Mellitus6
Diabetes Mellitus, Type 24
Macular Edema3
Angina Pectoris1
Cardiovascular Diseases1
Cataract1
Constriction, Pathologic1
Coronary Artery Disease1
Diabetes Complications1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.